Risk of Esophageal, Gastric Cancer Linked to Socioeconomic Status, Weight

This article originally appeared here.
Share this content:
Gastric, Esophageal Cancer Risk Linked to Teen Overweight
Gastric, Esophageal Cancer Risk Linked to Teen Overweight

(HealthDay News) -- Adolescents' weight and socioeconomic status (SES) may affect their subsequent risk of developing esophageal and gastric cancer, according to a study published online Oct. 15 in Cancer.

Zohar Levi, M.D., from Rabin Medical Center in Petach Tikva, Israel, and colleagues utilized body mass index measurements for one million Israeli adolescent males (mean age, 17.3 years) who underwent a general health examination from 1967 to 2005. Data were linked with the Israeli National Cancer Registry to identify incident cancer.

The researchers identified 182 incident cancer cases (52 combined esophageal adenocarcinoma [EAC] and gastroesophageal junction adenocarcinoma [GEJAC] cases and 130 noncardia gastric cancer [NCGC] cases). There was a significantly increased risk associated with adolescent overweight at baseline in the combined group of EAC and GEJAC cases (multivariable hazard ratio, 2.1).

There was an increased risk of intestinal-type NCGC associated with low SES (lowest versus highest category: multivariable hazard ratio, 2.2) and low number of years of education (no more than nine years: multivariable hazard ratio, 1.9). Immigrants born in Asian countries and the former Soviet Union had an increased adjusted risk of NCGC.

"Overweight during adolescence was found to be substantially associated with the subsequent development of EAC and GEJAC," the authors write. "Lower SES as well as immigration from higher-risk countries are important determinants of NCGC."

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs